SCOPUS 정보 검색 플랫폼

Toxicological Sciences

Volumn 60, Issue 1, 2001, Pages 20-27

PBPK modeling of canine inhalation exposures to halogenated hydrocarbons

(1) Vinegar, A a,b

a ALION SCIENCE AND TECHNOLOGY (United States)

b NONE (United States)

Author keywords

Canine; CFC 11; Desflurane; Halogenated hydrocarbons; Halothane; Isoflurane; PBPK model

Indexed keywords

CFC 11; CHLOROFLUOROCARBON; DESFLURANE; HALOGENATED HYDROCARBON; HALOTHANE; ISOFLURANE;

ANIMAL MODEL; ARTICLE; BLOOD LEVEL; BREATHING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DECISION MAKING; DOG; EXPOSURE; HEART OUTPUT; INFORMATION PROCESSING; LUNG DEAD SPACE; LUNG GAS EXCHANGE; NONHUMAN; PARAMETER; PRACTICE GUIDELINE; RESPIRATORY SYSTEM; SENSITIZATION; SIMULATION; TOXICOKINETICS; VALIDATION PROCESS;

ADMINISTRATION, INHALATION; ANIMALS; CHLOROFLUOROCARBONS, METHANE; DOGS; HALOTHANE; HUMANS; HYDROCARBONS, HALOGENATED; ISOFLURANE; MALE; MODELS, BIOLOGICAL;

ANIMALIA; CANIS FAMILIARIS;

EID: 0035095703 PISSN: 10966080 EISSN: None Source Type: Journal
DOI: 10.1093/toxsci/60.1.20 Document Type: Article

Times cited : (8)

References (21)

1
- 0017801116
- The hemodynamic effect of halothane in the normovolemic dog
- (1978) Acta Anaesthesiol. Scand. , vol.22 , pp. 83-92
- Ahlgren, I.¹ Aronsen, K.F.² Bjorkman, I.³ Wetterlin, S.⁴

2
- 0015834677
- Blood levels of fluorocarbon related to cardiac sensitization
- (1973) Am. Ind. Hyg. Assoc. J. , vol.34 , pp. 102-109
- Azar, A.¹ Trochimowicz, H.J.² Terrill, J.B.³ Mullin, L.S.⁴

3
- 0030806348
- Physiological parameter values for physiologically based pharmacokinetic models
- (1997) Toxicol. Ind. Health , vol.13 , pp. 407-484
- Brown, R.B.¹ Delp, M.D.² Lindstedt, S.L.³ Rhomberg, L.R.⁴ Beliles, R.P.⁵

4
- 0017295397
- Fluorocarbon aerosol propellants VIII: Solubility of trichloromonofluoromethane in dog blood and tissue homogenates
- (1976) J. Pharm. Sci. , vol.65 , pp. 53-55
- Chang, K.¹ Chiou, W.L.²

5
- 0015856951
- A simple and ultra-sensitive head-space gas chromatographic method for the assay of fluorocarbon propellants in blood
- (1973) Res. Comm. Chem. Pathol. Pharmacol. , vol.6 , pp. 481-498
- Chiou, W.L.¹ Niazi, S.²

6
- 0030018423
- Cardiopulmonary effects of desflurane in the dog during spontaneous and artificial ventilation
- (1996) Res. Vet. Sci. , vol.61 , pp. 82-86
- Clarke, K.W.¹ Alibhai, I.K.² Lee, Y.H.³ Hammond, R.A.⁴

7
- 0002994586
- Uptake and distribution
- 3rd ed. (R.D. Miller, Ed.), Churchill Livingstone, New York.
- (1990) In Anesthesia , pp. 85-104
- Eger II, E.I.¹

8
- 0023857245
- Influence of ventilatory and circulatory changes on the pharmacokinetics of halothane and isoflurane
- (1988) Experientia , vol.44 , pp. 178-181
- Frei, F.J.¹ Thomson, D.A.² Zbinden, A.M.³

9
- 0022741925
- Comparison of isoflurane and halothane as inhalation anaesthetics in the dog
- (1986) Vet. Q. , vol.8 , pp. 183-188
- Hellebrekers, L.J.¹

10
- 0017621633
- Absorption, biotransformation, and storage of halothane
- (1977) Environ. Health Perspect. , vol.21 , pp. 165-169
- Holaday, D.A.¹

11
- 0016766643
- Resistance of isoflurane to biotransformation in man
- (1975) Anesthesiology , vol.43 , pp. 325-332
- Holaday, D.A.¹ Fiserova-Bergerova, V.² Latto, I.P.³ Zumbiel, M.A.⁴

12
- 0019132020
- Effects of enflurane and thalothane on liver blood flow and oxygen consumption in the greyhound
- (1980) Br. J. Anaesth. , vol.52 , pp. 1079-1086
- Hughes, R.L.¹ Campbell, D.² Fitch, W.³

13
- 0016733943
- The solubility of thalothane in canine blood and tissues
- (1975) Br. J. Anaesth. , vol.47 , pp. 423-434
- Steward, A.¹ Allott, P.R.² Mapleson, W.W.³

14
- 0025741063
- Fluoride metabolites after prolonged exposure of volunteers and patients to desflurane
- (1991) Anesth. Analg. , vol.73 , pp. 180-185
- Sutton, T.S.¹ Koblin, D.D.² Gruenke, L.D.³ Weiskopf, R.B.⁴ Rampil, I.J.⁵ Waskell, L.⁶ Eger II, E.I.⁷

15
- 0005709359
- AMRL-TR-75-5. Aerospace Medical Research Laboratory, Wright-Patterson Air Force Base, OH.
- (1975) Biological-Mathematical Modeling of Chronic Toxicity.
- Thomas, V.¹

16
- 0005750593
- SNAP technical background document: Risk screen on the use of substitutes for class I ozone-depleting substances, fire suppression and explosion protection (Halon substitutes)
- U.S. EPA. U.S. Environmental Protection Agency, Office of Air and Radiation, Stratospheric Protection Division, Washington, DC.
- (1994)

17
- 0030220394
- Cardiac sensitization thresholds of halon replacement chemicals predicted in humans by physiologically based pharmacokinetic modeling
- (1996) Risk Anal. , vol.16 , pp. 571-579
- Vinegar, A.¹ Jepson, G.W.²

18
- 0033849760
- Setting safe acute exposure limits for halon replacement chemicals using physiologically based pharmacokinetic modeling
- (2000) Inhal. Toxicol. , vol.12 , pp. 751-763
- Vinegar, A.¹ Jepson, G.W.² Cisneros, M.³ Rubenstein, R.⁴ Brock, W.J.⁵

19
- 0031840654
- PBPK modeling of short-term (0 to 5 min) human inhalation exposures to halogenated hydrocarbons
- (1998) Inhal. Toxicol. , vol.10 , pp. 411-429
- Vinegar, A.¹ Jepson, G.W.² Overton, J.H.³

20
- 0005773471
- Use of a physiologically based pharmacokinetic model and computer simulation for retrospective assessment of exposure to volatile toxicants
- (1990) Inhal. Toxicol. , vol.2 , pp. 119-128
- Vinegar, A.¹ Winsett, D.W.² Andersen, M.E.³ Conolly, R.B.⁴

21
- 85033045691
- Rat to human extrapolation of HCFC-123 kinetics deduced from halothane kinetics: A corollary approach to physiologically based pharmacokinetic modeling
- (1996) Fundam. Appl. Toxicol. , vol.30 , pp. 55-66
- Williams, R.J.¹ Vinegar, A.² McDougal, J.N.³ Jarabek, A.M.⁴ Fisher, J.W.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.